Ftse Mib
33.766,29
-0,06%
DAX
19.884,75
-0,57%
S&P 500
5.930,85
1,09%
NASDAQ
19.572,60
1,03%
Bitcoin
97.509,09
-0,26%
Pepperstone
Advertisement
Registration Strip Icon for default Registrati gratuitamente per ottenere quotazioni in tempo reale, grafici interattivi, flusso di opzioni in tempo reale e altro ancora.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni Europa EU Sanofi (SAN) Sanofi (SAN) Notizie

Sanofi

SAN
91,28
-0,22 (-0,24%)
20 Dic 2024 - Chiuso
Dati in Delay di 15 minuti
Borsa: Euronext
Tipo: Azione Ordinaria
Valuta: EUR

Ultime notizie

Data Ora Fonte Titolo
19/12/202418:00UKREGPresse release: Jean-Paul Kress to join Sanofi's Board of..
19/12/202418:00UKREGCommuniqué de presse - Jean-Paul Kress rejoint le Conseil..
19/12/202418:00GLOBEPresse release: Jean-Paul Kress to join Sanofi's Board of..
17/12/202413:30GLOBEPress Release: Duvakitug positive phase 2b results..
17/12/202413:30UKREGPress Release: Duvakitug positive phase 2b results..
17/12/202413:30UKREGCommuniqué de presse : Les résultats positifs de phase IIb..
17/12/202407:30GLOBEPress Release: Availability of the Q4 2024 Aide-mémoire
17/12/202407:30UKREGCommuniqué de presse : Mise en ligne du document « Q4 2024..
17/12/202407:30UKREGPress Release: Availability of the Q4 2024 Aide-mémoire
13/12/202407:00GLOBEPress Release: Tolebrutinib designated Breakthrough Therapy..
13/12/202407:00UKREGPress Release: Tolebrutinib designated Breakthrough Therapy..
13/12/202407:00UKREGCommuniqué de presse : Le tolebrutinib obtient la..
11/12/202407:00GLOBEPress Release: Two combination vaccine candidates for..
11/12/202407:00UKREGCommuniqué de presse : Examen accéléré accordé aux..
11/12/202407:00UKREGPress Release: Two combination vaccine candidates for..
09/12/202420:06GLOBEPress Release: ASH: Sarclisa combinations demonstrated..
09/12/202420:06UKREGCommuniqué de presse : ASH : les associations thérapeutiques..
09/12/202420:06UKREGPress Release: ASH: Sarclisa combinations demonstrated..
07/12/202417:30GLOBEPress Release: ASH: rilzabrutinib demonstrated significant..
07/12/202417:30UKREGCommuniqué de presse : ASH : le rilzabrutinib a apporté un..
07/12/202417:30UKREGPress Release: ASH: rilzabrutinib demonstrated significant..
06/12/202407:30GLOBEPress Release: Availability of the revised financial..
06/12/202407:30UKREGPress Release: Availability of the revised financial..
06/12/202407:30UKREGCommuniqué de presse : Mise en ligne des états financiers..
20/11/202414:11UKREGSanofi: Informations relatives au nombre de droits de vote..
20/11/202414:11UKREGSanofi: Information concerning the total number of voting..
15/11/202407:00UKREGCommuniqué de presse : La FDA a accepté l’examen de la sBLA..
15/11/202407:00GLOBEPress Release: Dupixent sBLA accepted for FDA review for the..
15/11/202407:00UKREGPress Release: Dupixent sBLA accepted for FDA review for the..
14/11/202417:42GLOBEPress Release: Sarclisa recommended for EU approval by the..
14/11/202417:42UKREGCommuniqué de presse : Sarclisa : approbation recommandée..
14/11/202417:42UKREGPress Release: Sarclisa recommended for EU approval by the..
06/11/202407:00UKREGCommuniqué de presse : Dupixent, premier et seul médicament..
06/11/202407:00UKREGPress Release: Dupixent approved in the EU as the first and..
06/11/202407:00GLOBEDupixent® (dupilumab) Approved in the European Union as the..
25/10/202412:07IHMARKETNEWSUS Futures Rise; Oil Prices Edge Higher
25/10/202407:30UKREGPress Release: Sanofi Q3: 15.7% sales growth boosted by..
25/10/202407:30UKREGCommuniqué de presse : T3 2024 : Croissance des ventes de..
25/10/202407:30GLOBEPress Release: Sanofi Q3: 15.7% sales growth boosted by..
24/10/202414:00UKREGPress Release: Dupixent late-breaking positive phase 3 data..
24/10/202414:00UKREGCommuniqué de presse : Dupixent : Présentation de nouvelles..
24/10/202414:00GLOBEPress Release: Dupixent late-breaking positive phase 3 data..
21/10/202407:30UKREGCommuniqué de presse : Sanofi et CD&R s’allient pour..
21/10/202407:30GLOBEPress Release: Sanofi and CD&R partner to fuel Opella’s..
21/10/202407:30UKREGPress Release: Sanofi and CD&R partner to fuel Opella’s..
17/10/202407:30UKREGCommuniqué de presse : Sanofi et Orano Med unissent leurs..
17/10/202407:30UKREGPress Release: Sanofi and Orano join forces to develop..
17/10/202407:30UKREGPress Release: Sanofi and Orano join forces to develop..
17/10/202407:30GLOBEPress Release: Sanofi and Orano join forces to develop..
17/10/202407:30UKREGCommuniqué de presse : Sanofi et Orano Med unissent leurs..
Apertura: 90,89 Min: 89,93 Max: 91,62
Chiusura: 91,50

La tua Cronologia

EU
SAN
Sanofi
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network